Smith Stan 4
4 · MAIA Biotechnology, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
2025-10-01$1.30/sh+19,230$24,999→ 1,324,289 total(indirect: See Footnote) - Purchase
Warrants
2025-10-01$1.57/sh+19,230$30,191→ 19,230 total(indirect: See footnote)Exercise: $1.57From: 2026-04-01Exp: 2028-10-01→ Common Stock (19,230 underlying)
Footnotes (4)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on October 1, 2025
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on October 1, 2025. The options are exercisable beginning on the six-month anniversary of the issuance date and expire 3-years after the initial issuance date.
- [F4]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.